Skip to main content
OpenTrials
Completed

NCT Number: NCT04758689

Laser Acupuncture in Rheumatoid Arthritis Geriatric Patients

Studying the effect of laser acupuncture on geriatric patients with rheumatoid arthritis

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Rheumatoid Arthritis Arthritis Arthritis, Rheumatoid Autoimmune Diseases Connective Tissue Diseases Immune System Diseases Joint Diseases Musculoskeletal Diseases Rheumatic Diseases Skin and Connective Tissue Diseases

Age range

65 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

A. Sedky

Cairo, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients referred from physician (immunologist) diagnosed with rheumatoid arthritis.

Exclusion criteria

  • Patients having the disease overlapping with other connective tissue diseases, such as systematic lupus erythromatosus and systematic sclerosis.
  • History of malignancies.

Treatment and study plan

Laser, exercise, and methotrexate

Combination Product

Laser therapy at acupuncture points, aerobic exercise, and methotrexate

Exercise, and methotrexate

Combination Product

Aerobic exercise, and methotrexate

Primary outcomes

  1. Interleukin 6 (IL-6)

    Time frame: Baseline

    interleukin 6

  2. Interleukin 6 (IL-6)

    Time frame: 4 weeks

    interleukin 6

  3. Malondialdehyde (MDA)

    Time frame: Baseline

    malondialdehyde

  4. Malondialdehyde (MDA)

    Time frame: 4 weeks

    malondialdehyde

  5. Adenosine Triphosphate (ATP)

    Time frame: Baseline

    adenosine triphosphate

  6. Adenosine Triphosphate (ATP)

    Time frame: 4 weeks

    adenosine triphosphate

  7. C-Reactive Protein (CRP)

    Time frame: Baseline

    C-reactive protein

  8. C-Reactive Protein (CRP)

    Time frame: 4 weeks

    C-reactive protein

Secondary outcomes

  1. Rheumatoid Arthritis Quality of Life (RAQoL)

    Time frame: Baseline

    rheumatoid arthritis quality of life

  2. Rheumatoid Arthritis Quality of Life (RAQoL)

    Time frame: 4 weeks

    rheumatoid arthritis quality of life

  3. Health Assessment Questionnaire (HAQ)

    Time frame: Baseline

    health assessment questionnaire

  4. Health Assessment Questionnaire (HAQ)

    Time frame: 4 weeks

    health assessment questionnaire

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Feb 17, 2021
Registry last updated
May 6, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.